Johannes Vieweg

Q: What Schools Are Affiliated With Johannes Vieweg

Johannes Vieweg is affiliated with the following schools: Nova Southeastern University, University of Florida, University of Florida College of Medicine, Duke University

Johannes Vieweg's AcademicInfluence.com Rankings

Johannes Vieweg

Philosophy

#11593

World Rank

#15997

Historical Rank

Logic

#8457

World Rank

#10584

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Johannes Vieweg Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Johannes W. Vieweg is an American medical school dean, university professor, and physician-scientist, presently residing in the city of Fort Lauderdale, Florida. Early life and education Vieweg received his medical degree from the Technical University of Munich in 1983. After relocating to the United States, in 1991, he spent three years as a post-doctoral research fellow at Memorial Sloan-Kettering Cancer Center, New York, NY and Duke University, Durham, NC under the mentorship of Eli Gilboa, PhD, a prominent expert in retrovirology and cell therapy.

(See a Problem?)

Johannes Vieweg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. (2005) (1021)
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. (2002) (534)
Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. (2003) (387)
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. (2000) (372)
Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1 (2005) (340)
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials (2010) (335)
Cancer immunotherapy with mRNA‐transfected dendritic cells (2004) (322)
Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma (2008) (288)
Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma1 (2008) (243)
Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA1 (2001) (207)
Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. (1994) (206)
Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. (1999) (195)
Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation 1 (2003) (182)
Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. (2011) (182)
Synergy between tumor immunotherapy and antiangiogenic therapy. (2003) (177)
Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer (2012) (174)
Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain. (1998) (168)
Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro1 (2000) (159)
Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. (2001) (157)
Pivotal Advance: Tumor‐mediated induction of myeloid‐derived suppressor cells and M2‐polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells (2010) (145)
Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. (2010) (138)
Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. (2002) (125)
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand. (2005) (125)
Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. (2000) (105)
The impact of primary stage on survival in patients with lymph node positive bladder cancer. (1999) (105)
Reversal of Tumor-Mediated Immunosuppression (2007) (92)
A Novel DNMT3B Splice Variant Expressed in Tumor and Pluripotent Cells Modulates Genomic DNA Methylation Patterns and Displays Altered DNA Binding (2009) (83)
Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. (1995) (79)
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer (2009) (76)
A Critical Assessment of the Quality of Reporting of Randomized, Controlled Trials in the Urology Literature (2007) (73)
Trifecta nerve complex: potential anatomical basis for microsurgical denervation of the spermatic cord for chronic orchialgia. (2013) (70)
Radical Cystectomy for Invasive Bladder Cancer: Contemporary Results and Remaining Controversies (2000) (68)
Female fertility following extracorporeal shock wave lithotripsy of distal ureteral calculi. (1992) (67)
Urolithiasis: detection and management with unenhanced spiral CT--a urologic perspective. (1998) (67)
Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 41 (2004) (66)
Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages. (2016) (64)
Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer? (1997) (59)
Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation. (2016) (59)
E-cadherin plasticity in prostate cancer stem cell invasion. (2011) (57)
Differentiation of Human Embryonic Stem Cells into Immunostimulatory Dendritic Cells under Feeder-Free Culture Conditions (2008) (56)
Cell‐based selection provides novel molecular probes for cancer stem cells (2013) (55)
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine (2010) (55)
Factors associated with the full publication of studies presented in abstract form at the annual meeting of the American Urological Association. (2007) (54)
Expansion of CCR8+ Inflammatory Myeloid Cells in Cancer Patients with Urothelial and Renal Carcinomas (2013) (52)
Comparison of Ultrasound-Guided Biopsies and Prostatectomy Specimens: Predictive Accuracy of Gleason Score and Tumor Site (2001) (49)
Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position. (1998) (49)
Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. (1995) (48)
Levels of evidence in the urological literature. (2007) (46)
Immunotherapy of cancer using cytokine gene-modified tumor vaccines. (1994) (43)
Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy. (2007) (41)
Urinary continence and quality of life in the first year after radical perineal prostatectomy. (2003) (40)
Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells. (2011) (39)
Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference (2007) (39)
Clinical practice guidelines on prostate cancer: a critical appraisal. (2015) (39)
A longitudinal assessment of bowel related symptoms and fecal incontinence following radical perineal prostatectomy. (2003) (37)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma (2016) (36)
Enhancing the efficacy of cancer vaccines in urologic oncology: new directions (2009) (33)
Prospective and longitudinal patient self-assessment of health-related quality of life following radical perineal prostatectomy. (2004) (32)
Interobserver variability in the interpretation of unenhanced helical CT for the diagnosis of ureteral stone disease. (1998) (31)
Antigenic targets for renal cell carcinoma immunotherapy (2004) (27)
Modulation of antitumor responses by dendritic cells (2004) (27)
Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. (2008) (26)
An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer (1994) (25)
Technology Insight: vaccine therapy for prostate cancer (2005) (25)
Reporting quality and information consistency of randomized, controlled trials presented as abstracts at the American Urological Association annual meetings. (2010) (25)
Evaluating the evidence: the methodological and reporting quality of comparative observational studies of surgical interventions in urological publications (2009) (23)
Combination Therapy for Renal Cell Cancer: What Are Possible Options? (2011) (22)
Vaccines in renal cell carcinoma. (2006) (21)
Prospective evaluation of pain medication requirements and recovery after radical perineal prostatectomy. (2003) (21)
Immunotherapy for advanced prostate cancer. (2007) (19)
When to diagnose and how to treat prostate cancer in the "not too fit" elderly. (2003) (18)
[Primary management of fresh injuries of the thoracic and lumbar vertebrae]. (1991) (16)
Study characteristics of abstracts presented at the annual meetings of the southeastern section of the American Urological Association (1996-2005). (2008) (16)
Enhancement of antitumor immunity following depletion of CD4+CD25+ regulatory T cells. (2004) (15)
How does the immune system attack cancer (2004) (15)
Radical perineal prostatectomy for treatment of localized prostate cancer in obese and nonobese patients: a matched control study. (2005) (14)
Immunotherapy of surgical malignancies. (2004) (12)
The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy. (2007) (10)
Tumor vaccines: from gene therapy to dendritic cells--the emerging frontier. (2003) (10)
233: Factors Associated with the Full Publication of Studies Presented in Abstract form at the Annual Meeting of the AUA (2006) (10)
Metastatic Prostate Cancer T Cell Responses in Patients with + CD4 and + Cells Stimulate Antigen-Specific CD8 Telomerase mRNA-Transfected Dendritic (2005) (9)
A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. (2008) (9)
Gene therapy approaches in urologic oncology. (1995) (9)
In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy (2006) (8)
Human robotic assisted bilateral vasoepididymostomy and vasovasostomy procedures: initial safety and efficacy trial (2009) (8)
Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings. (2009) (8)
Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical cancer involvement (2007) (7)
Prostate cancer: targeting complexity. (2008) (7)
Mechanism for Immune Evasion in Cancer Tumor-Infiltrated CD11b Myeloid Cells: A 15-Hydroxyprostaglandin Dehydrogenase in Altered Expression of (2009) (6)
CLINICAL PRACTICE GUIDELINES FOR PROSTATE CANCER: A CRITICAL APPRAISAL OF METHODOLOGICAL QUALITY (2008) (5)
1880 TRIFECTA OF PAIN: ANATOMIC BASIS FOR DENERVATION OF THE SPERMATIC CORD FOR CHRONIC ORCHIALGIA (2010) (5)
1610: Impact of the Nerve-Sparing Technique on Patients Selfassessed Functional Outcomes in Radical Perineal Prostatectomy (2006) (4)
[Intra- and postoperative morbidity of radical prostatectomy]. (1991) (4)
Radical perineal prostatectomy: a model for evaluating local response of prostate therapy. (2002) (3)
Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure. (1991) (3)
Future directions for vaccine-based therapies. (2006) (3)
INTEROBSERVER AGREEMENT IN THE APPLICATION OF LEVELS OF EVIDENCE RATINGS TO THE UROLOGICAL LITERATURE (2008) (3)
Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial. (2004) (3)
Transitioning to Value-Based Diabetes Care: A Call for Action Derived from Primary Care Providers in South Florida (2020) (2)
Human Cancer Biology Expansion of CCR 8 þ In fl ammatory Myeloid Cells in Cancer Patients with Urothelial and Renal Carcinomas (2013) (2)
Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC). (2006) (2)
Outcome profiles of locoregional disease after radical prostatectomy and radiotherapy (2000) (2)
15: Levels of Evidence in the Urology Literature (2007) (2)
Reversal of immature myeloid cell-mediated immunosuppression (2005) (2)
39 RESIDENTS FOR QUALITY IMPROVEMENT IN UROLOGY (RESQU): THREE YEAR EXPERIENCE WITH A RESIDENT-CENTERED QUALITY IMPROVEMENT INITIATIVE (2011) (1)
Abstract 485: Hypoxia increases the expression of stem-cell markers and promotes cell invasion in prostate cancer cells (2011) (1)
MP58-09 HYDROXYAPATITE INDUCES CALCIUM OXALATE TOLERANCE IN PRIMARY HUMAN MONOCYTES (2016) (1)
AN OBSERVATIONAL STUDY OF THE INFORMATION CONSISTENCY OF UROLOGICAL ABSTRACTS AND SUBSEQUENT FULL-TEXT PUBLICATIONS (2009) (1)
[Basic principles of gene therapy]. (1996) (1)
The evolving role of dendritic cell therapy in urologic oncology (2000) (1)
PERCEPTIONS AND COMPETENCE IN EVIDENCE-BASED MEDICINE: RESULTS OF THE 2006 SURVEY OF AUA MEMBERS (2008) (1)
[Post-ischemia normal function of living related kidney transplants after preservation with HTK solution]. (1991) (1)
A tribute to the life and accomplishments of Birdwell Finlayson. (2007) (1)
398: Enhancement of Vaccine-Mediated Antitumor Immunity in Renal Cell Carcinoma (RCC) Patients after in vivo Depletion of Regulatory T Cells. Results from a Phase-I Clinical Trial (2006) (1)
Dendritic cell-based cancer immunotherapy (2002) (1)
470 E-cadherin plasticity in tumor-initiating stem-like cells regulates prostate cancer cell invasion (2010) (1)
Future Perspectives: Immunotherapy and Vaccines in Prostate Cancer (2004) (1)
EVALUATING THE EVIDENCE: QUALITY OF REPORTING OF STUDIES ON ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY (2008) (1)
EVIDENCE BASED MEDICINE TRAINING IN RESIDENCY: A SURVEY OF UROLOGY PROGRAM DIRECTORS (2008) (1)
Outcomes/Epidemiology/Socioeconomics PROSPECTIVE AND LONGITUDINAL PATIENT SELF-ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE FOLLOWING RADICAL PERINEAL PROSTATECTOMY (2004) (0)
Handheld intra-operative doppler flow to localize the presence of sperm during testis biopsy in azoospermic men (2008) (0)
Variations in Opioid Use following Robotic Radical Prostatectomy in South Florida. (2022) (0)
MP25-12 HUMAN MACROPHAGES FACILITATE KIDNEY STONE CLEARANCES (2014) (0)
DIAMOND 4-ARM PORT CONFIGURATION FOR SINGLE DOCKING ROBOTIC RENAL SURGERY (2009) (0)
408: Targeted Immunotherapy Against Genitourinary Malignancies using RNA-Transfected DC Vaccines (2005) (0)
Abstract B13: Prostate cancer immunotherapy development using tumor-specific CAR design (2015) (0)
INTRA-OPERATIVE DOPPLER PHASE SHIFT TO LOCALIZE THE PRESENCE OF SPERM DURING TESTIS BIOPSY IN AZOOSPERMIC MEN (2009) (0)
[Validity of nuclear magnetic resonance tomography in evaluation of the traumatized intervertebral disk]. (1991) (0)
[A new concept in teaching First Aid. Questioning shows: education according to the care-centered first aid concept is judged positively]. (1995) (0)
Abstract A5: Functional role of SOX2 in hypoxia-mediated metastasis-associated functions in prostate cancer (2013) (0)
144: A Prospective Longitudinal Study of Quality of Life Following Radical Perineal Prostatectomy (2004) (0)
Editorial introductions. (2019) (0)
440: Barriers to the Practice of Evidence Based Urology in the United States (2007) (0)
Immunologic targeting of genitourinary malignancies (2005) (0)
236: Safety and Efficacy of Human Telomerase Reverse Transcriptase Rna Transfected Dendritic Cells in Patients with Metastatic Prostate Cancer: Results of a Phase I Clinical Trial (2005) (0)
59 ENROLLMENT OF BLACK MEN IN PROSTATE CANCER RANDOMIZED CONTROLLED TRIALS (2013) (0)
[Cardiopulmonary resuscitation]. (1993) (0)
Abstract 5328: Expansion of CD11b+CD33lowCD15highimmunosuppressive myeloid cell population in patients with bladder carcinoma (2010) (0)
Stimulation of Potent Antigen-Specific T-Cell Responses Using Semiallogenic Dendritic Cells Derived from Human Embryonic Stem Cells. (2006) (0)
Delivery of mRNA into Dendritic Cells Using Novel Transfer Peptides Leads to Prolonged Antigen Expression and Potent Immune Responses In Vivo. (2007) (0)
Oxidative stress regulates expression of VEGFR1+ in myeloid cells: Link to angiogenesis and tumor-induced immune suppression in renal cell carcinoma (2008) (0)
439: Evaluating the Evidence: Statistical Analysis in Randomized Controlled Trials in the Urology Literature (2007) (0)
Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine. (2020) (0)
637: Establishing a Porcine Model for the Accelerated Development of Cancer Vaccines for Patients with Metastatic Renal Cell Carcinoma (2005) (0)
397: Identification of Angiogenesis-Associated Gene Products for Renal Cell Carcinoma Immunotherapy (2006) (0)
Concomitant Induction of CMVpp65-Specific CD4+ and CD8+ T Cells Using Dendritic Cells Transfected with mRNA Encoding an Invariant Chain-pp65 Fusion Protein. (2005) (0)
VIDEO DEMONSTRATION OF ROBOTIC TESTICULAR SPERM EXTRACTION: CRITICAL EVALUATION COMPARED TO OPEN TESE AND PERCUTANEOUS NEEDLE LAVAGE TECHNIQUES IN CANINE MODEL AND THE FIRST HUMAN CASES (2008) (0)
1127: Generation of Semiallogenic Dendritic Cells Derived from Human Embryonic Stem Cells for Urologic Cancer Immunotherapy (2007) (0)
Enhancement of Anti-Telomerase Immunity Against Prostate Cancer (2007) (0)
Award Number : W 81 XWH-051-0011 TITLE : Enhancement of Anti-telemorase Immunity Against Prostate Cancer (2010) (0)
MP33-09 HUMAN MONOCYTE-DERIVED MACROPHAGES ARE ABLE TO DESTROY KIDNEY STONES (2015) (0)
442 Long term quality of life after radical perineal prostatectomy (2004) (0)
Editorial comment. (2012) (0)
Receptor 4 Encoding a Dominant Positive Toll-Like Maturation Using Transfection with RNA Induction of Human Dendritic Cell (2004) (0)
Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma? (2005) (0)
Vaccine-Based Immunotherapy and Targeting the Tumor Microenvironment in Renal Cell Carcinoma (2012) (0)
Redesign of US Medical Schools: A Shift from Health Service to Population Health Management. (2021) (0)
Validity of magnetic resonance imaging in the diagnosis of injured intervertebral discs (1991) (0)
Seminar article Future directions for vaccine-based therapies (2006) (0)
Management Principles to Drive the Creation of a 21st Century Medical School (2020) (0)
Principles of cancer gene therapy (1996) (0)
10: Prospective Comparison of the Health-Related Quality of Life Outcomes of Radical Robotic and Perineal Prostatectomy (2007) (0)
The evolving therapeutic landscape of prostate cancer. (2007) (0)
THE REPORTING QUALITY OF RANDOMIZED CONTROLLED TRIALS PRESENTED IN ABSTRACT FORM AT THE AMERICAN UROLOGICAL ASSOCIATION ANNUAL MEETING (2009) (0)
COMMENT ON : UNENHANCED HELICAL COMPUTERIZED TOMOGRAPHY FOR THE EVALUATIONOF PATIENTS WITH ACUTE FLANK PAIN. AUTHOR'S REPLY (1999) (0)
235: Evaluating the Evidence: Randomized Controlled Trial Reporting in the Urologic Literature (2006) (0)
VIDEO DEMONSTRATION OF LAPAROSCOPIC DOPPLER IDENTIFICATION OF CROSSING VESSEL DURING ROBOTIC OR LAPAROSCOPIC DISMEMBERED PYELOPLASTY – A POSSIBLE TOOL TO DECREASE OPERATIVE TIME? (2008) (0)

This paper list is powered by the following services:

Other Resources About Johannes Vieweg

en.wikipedia.org

What Schools Are Affiliated With Johannes Vieweg?

Johannes Vieweg is affiliated with the following schools:

Johannes Vieweg's Academic­Influence.com Rankings